IN8bio, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:INAB) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 20.94 M19.87 M19.37 M16.77 M32.28 M26.27 M 負債合計 6.47 M5.99 M4.13 M3.58 M4.72 M3.48 M 純資産合計 14.48 M13.88 M15.24 M13.19 M27.56 M22.78 M 負債および純資産合計 20.94 M19.87 M19.37 M16.77 M32.28 M26.27 M 有利子負債合計 —————— 純負債 ——————

ニュース

H.C. Wainwrightが資金調達力を評価しIN8bio株の投資判断を維持

H.C. Wainwright reiterates IN8bio stock rating on financing strength

IN8bio、Kate Rochlinを社長に任命、COO職も継続

IN8bio appoints Kate Rochlin as president while retaining COO role

IN8bio promotes Kate Rochlin to president and chief operating officer

IN8bio、がん治療のために最大4,020万ドルのプライベートプレースメントを確保

IN8bio secures up to $40.2 million in private placement for cancer therapy

みずほ、資金調達懸念でIN8bio株価目標を引き下げ

Mizuho lowers IN8bio stock price target on financing concerns

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

INB-200 shows promise in glioblastoma trial

IN8bio reports promising lupus treatment data